| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Autologous stem cell transplantation in multiple myeloma patients with renal impairment
|
Zhai, Yingying
|
|
|
102 |
3 |
p. 621-628
|
artikel
|
| 2 |
Can we lower the platelet threshold of ≥ 50 × 109/L for performing a lumbar puncture safely in patients with hematological malignancies?
|
Jordan, Aryanna
|
|
|
102 |
3 |
p. 663-668
|
artikel
|
| 3 |
Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
|
Park, Woochan
|
|
|
102 |
3 |
p. 629-639
|
artikel
|
| 4 |
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study
|
Niederwieser, Dietger
|
|
|
102 |
3 |
p. 547-561
|
artikel
|
| 5 |
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis
|
Cioccio, Joseph
|
|
|
102 |
3 |
p. 613-620
|
artikel
|
| 6 |
FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis
|
Mao, Shihui
|
|
|
102 |
3 |
p. 583-595
|
artikel
|
| 7 |
Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
|
Kamijo, Kimimori
|
|
|
102 |
3 |
p. 651-661
|
artikel
|
| 8 |
GP1BB c.179C > T is the most frequent cause of monoallelic Bernard–Soulier syndrome in the Italian population after the Bolzano variant: a report of two new families
|
Barozzi, Serena
|
|
|
102 |
3 |
p. 677-679
|
artikel
|
| 9 |
Mass cytometry analysis identifies T cell immune signature of aplastic anemia and predicts the response to cyclosporine
|
Zhang, Lele
|
|
|
102 |
3 |
p. 529-539
|
artikel
|
| 10 |
Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
|
Stanulla, Martin
|
|
|
102 |
3 |
p. 669-672
|
artikel
|
| 11 |
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers
|
Frank, Benedikt
|
|
|
102 |
3 |
p. 603-611
|
artikel
|
| 12 |
Persistent splenomegaly due to littoral cell angiomatosis in venetoclax-induced undetectable minimal residual disease of chronic lymphocytic leukemia
|
Cellini, Alessandro
|
|
|
102 |
3 |
p. 681-682
|
artikel
|
| 13 |
Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course
|
Delehaye, Fanny
|
|
|
102 |
3 |
p. 563-570
|
artikel
|
| 14 |
Real-world treatments and thrombotic events in polycythemia vera patients in the USA
|
Verstovsek, Srdan
|
|
|
102 |
3 |
p. 571-581
|
artikel
|
| 15 |
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA)
|
van Yperen, Nicole C.
|
|
|
102 |
3 |
p. 641-649
|
artikel
|
| 16 |
Sense of coherence or self-efficacy as predictors of health-related quality of life in sickle cell disease patients
|
Ahmadi, Mehrnaz
|
|
|
102 |
3 |
p. 519-528
|
artikel
|
| 17 |
Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia
|
Aiba, Masayuki
|
|
|
102 |
3 |
p. 541-546
|
artikel
|
| 18 |
Tacrolimus-induced thrombotic microangiopathy post-liver transplantation for cryptogenic acute liver failure in an infant
|
Wujek, Carly
|
|
|
102 |
3 |
p. 687-688
|
artikel
|
| 19 |
The incidence and characteristics of VTE within 100 days of CAR T-cell therapy
|
Gaffney, Kelly J.
|
|
|
102 |
3 |
p. 683-685
|
artikel
|
| 20 |
Thyrotoxicosis after unrelated cord blood transplantation for adults
|
Konuma, Takaaki
|
|
|
102 |
3 |
p. 673-676
|
artikel
|
| 21 |
Venetoclax-based combination therapy in R/R DLBCL patients with failure of CAR-T therapy
|
Zhu, Ying
|
|
|
102 |
3 |
p. 597-601
|
artikel
|
| 22 |
Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study
|
Shen, Yingying
|
|
|
102 |
3 |
p. 503-517
|
artikel
|
Tijdschrift beschrijving